Baloxavir
Baloxavir (S-033447) is a novel small-molecule inhibitor that selectively targets the PA subunit of the influenza virus polymerase, acting via cap-dependent endonuclease inhibition. It is widely used in antiviral research for both in vitro mechanistic studies and in vivo efficacy models, supporting the development of novel anti-influenza therapeutics.
Product Specifications
CAS Number
1985605-59-1
Product Name Alternative
Dolutegravir, CEN, Baloxavir, Baloxavir acid, BXA, cap-dependent, InfluenzaVirus, Influenza Virus, Influenza virus, influenza, endonuclease, RNA, S 033447, S033447, S-033447, transcription
Field of Research
Infectious Disease & Virology
Purity
99.26% (May vary between batches)
Solubility
DMSO:46 mg/mL (95.14 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.14 mM)
Smiles
Oc1c2C (=O) N3CCOC[C@H]3N ([C@@H]3c4ccccc4SCc4c (F) c (F) ccc34) n2ccc1=O
Molecular Formula
C24H19F2N3O4S
Molecular Weight
483.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
